Back to Back Issues Page | ||||||||||
FDA Citations and SOP's. May 31, 2015 |
||||||||||
FDA Citations and SOP's.Can SOP's reduce or even stopped the FDA raising citations for cGMP delinquencies? Well perhaps if the SOP is used as a whipping stick – to lash us all into a state where we will accept that repeated audits failures are bad when they are highlighted by in house audits – but can become catastrophic when highlighted by our regulators. Then surely it is time for us to repeat the in house audits until we are consistently demonstrating 100% compliance. We have on offer today four SOP’s that cover 75% of adverse warning letter comments. We have grouped them together and are offering them at a price that they could never be individually authored and produced for. Don’t miss this offer it will not be made permanent. To publish ready-to-use documentation would of coarse be commercial suicide; so we have left the text unintelligible. This allows you to get a feel for the quality and scope of the document whilst leaving our proprietary rights reasonably safe. Enjoy.
SOP Quartet Package Offer Four superb tried and tested Standard Operating Practice documents; almost for the price of one. 10000132_SOP_Package_issue-2. -- $169.00 |
||||||||||
Back to Back Issues Page |